Should We Disclose Amyloid Imaging Results to Cognitively Normal Individuals?
Authors:
- 31 January 2013
- journal article
- Published by Taylor & Francis in Neurodegenerative Disease Management
- Vol. 3 (1) , 43-51
Abstract
SUMMARY Demonstration of brain accumulation of fibrillar amyloid-β protein via PET with amyloid-specific ligands may support the diagnosis of Alzheimer’s disease (AD). There is increasing recognition of the potential use of amyloid imaging to detect the pathology of AD in vivo in individuals with no ostensible cognitive impairment. Research use of amyloid PET in cognitively normal patients will be key to the pursuit of therapies able to delay cognitive impairment and dementia due to AD. We review the pros and cons of disclosing amyloid imaging results to cognitively normal individuals in clinical and research settings and provide draft recommendations.Keywords
This publication has 67 references indexed in Scilit:
- Amyloid‐beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B dataAnnals of Neurology, 2011
- Amyloid‐β associated volume loss occurs only in the presence of phospho‐tauAnnals of Neurology, 2011
- Amyloid‐β associated cortical thinning in clinically normal elderlyAnnals of Neurology, 2010
- Exercise and Alzheimer's disease biomarkers in cognitively normal older adultsAnnals of Neurology, 2010
- Cerebrospinal Fluid Abnormalities and Rate of Decline in Everyday Function Across the Dementia SpectrumArchives of Neurology, 2010
- Cognition, reserve, and amyloid deposition in normal agingAnnals of Neurology, 2010
- Absence of Pittsburgh Compound B Detection of Cerebral Amyloid β in a Patient With Clinical, Cognitive, and Cerebrospinal Fluid Markers of Alzheimer DiseaseArchives of Neurology, 2009
- Cognitive Decline and Brain Volume Loss as Signatures of Cerebral Amyloid-β Peptide Deposition Identified With Pittsburgh Compound BArchives of Neurology, 2009
- Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer DiseaseArchives of Neurology, 2009
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the ElderlyArchives of Neurology, 2008